vs
BANK OF HAWAII CORP（BOH）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是BANK OF HAWAII CORP的1.1倍（$207.3M vs $192.3M），BANK OF HAWAII CORP净利率更高（29.9% vs -62.0%，领先91.9%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 10.7%）
夏威夷银行是美国夏威夷州的区域性商业银行，总部位于檀香山，是夏威夷第二古老的银行，也是当地最大的本土银行，多数表决权股东均居住在州内。该行的账户数、客户规模、营业网点及ATM数量均居夏威夷金融机构首位，业务涵盖零售银行、商业银行、投资服务、资金运营四大板块。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BOH vs RARE — 直观对比
营收规模更大
RARE
是对方的1.1倍
$192.3M
净利率更高
BOH
高出91.9%
-62.0%
两年增速更快
RARE
近两年复合增速
10.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $192.3M | $207.3M |
| 净利润 | $57.4M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 29.9% | -62.0% |
| 营收同比 | — | 25.9% |
| 净利润同比 | 30.6% | 3.5% |
| 每股收益（稀释后） | $1.30 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BOHRARE
| Q1 26 | $192.3M | — | ||
| Q4 25 | $189.6M | $207.3M | ||
| Q3 25 | $182.6M | $159.9M | ||
| Q2 25 | $174.5M | $166.5M | ||
| Q1 25 | $169.9M | $139.3M | ||
| Q4 24 | $163.2M | $164.6M | ||
| Q3 24 | $162.7M | $139.5M | ||
| Q2 24 | $156.9M | $147.0M |
净利润BOHRARE
| Q1 26 | $57.4M | — | ||
| Q4 25 | $60.9M | $-128.6M | ||
| Q3 25 | $53.3M | $-180.4M | ||
| Q2 25 | $47.6M | $-115.0M | ||
| Q1 25 | $44.0M | $-151.1M | ||
| Q4 24 | $39.2M | $-133.2M | ||
| Q3 24 | $40.4M | $-133.5M | ||
| Q2 24 | $34.1M | $-131.6M |
营业利润率BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | -54.7% | ||
| Q3 25 | 37.1% | -106.9% | ||
| Q2 25 | 34.6% | -64.8% | ||
| Q1 25 | 33.1% | -102.6% | ||
| Q4 24 | 31.6% | -74.3% | ||
| Q3 24 | 32.3% | -94.6% | ||
| Q2 24 | 28.9% | -79.1% |
净利率BOHRARE
| Q1 26 | 29.9% | — | ||
| Q4 25 | 32.1% | -62.0% | ||
| Q3 25 | 29.2% | -112.8% | ||
| Q2 25 | 27.3% | -69.0% | ||
| Q1 25 | 25.9% | -108.5% | ||
| Q4 24 | 24.0% | -80.9% | ||
| Q3 24 | 24.8% | -95.7% | ||
| Q2 24 | 21.7% | -89.5% |
每股收益（稀释后）BOHRARE
| Q1 26 | $1.30 | — | ||
| Q4 25 | $1.40 | $-1.28 | ||
| Q3 25 | $1.20 | $-1.81 | ||
| Q2 25 | $1.06 | $-1.17 | ||
| Q1 25 | $0.97 | $-1.57 | ||
| Q4 24 | $0.85 | $-1.34 | ||
| Q3 24 | $0.93 | $-1.40 | ||
| Q2 24 | $0.81 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $-80.0M |
| 总资产 | $23.9B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BOHRARE
| Q1 26 | $3.3M | — | ||
| Q4 25 | $946.5M | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | $935.2M | $127.1M | ||
| Q4 24 | $763.6M | $174.0M | ||
| Q3 24 | $1.3B | $150.6M | ||
| Q2 24 | $925.3M | $480.7M |
总债务BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | $558.2M | — | ||
| Q3 25 | $558.2M | — | ||
| Q2 25 | $558.2M | — | ||
| Q1 25 | $558.3M | — | ||
| Q4 24 | $558.3M | — | ||
| Q3 24 | $558.3M | — | ||
| Q2 24 | $560.1M | — |
股东权益BOHRARE
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $-80.0M | ||
| Q3 25 | $1.8B | $9.2M | ||
| Q2 25 | $1.7B | $151.3M | ||
| Q1 25 | $1.7B | $144.2M | ||
| Q4 24 | $1.7B | $255.0M | ||
| Q3 24 | $1.7B | $346.8M | ||
| Q2 24 | $1.6B | $432.4M |
总资产BOHRARE
| Q1 26 | $23.9B | — | ||
| Q4 25 | $24.2B | $1.5B | ||
| Q3 25 | $24.0B | $1.2B | ||
| Q2 25 | $23.7B | $1.3B | ||
| Q1 25 | $23.9B | $1.3B | ||
| Q4 24 | $23.6B | $1.5B | ||
| Q3 24 | $23.8B | $1.5B | ||
| Q2 24 | $23.3B | $1.6B |
负债/权益比BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | $218.3M | $-99.8M | ||
| Q3 25 | $38.5M | $-91.4M | ||
| Q2 25 | $81.7M | $-108.3M | ||
| Q1 25 | $18.3M | $-166.5M | ||
| Q4 24 | $170.9M | $-79.3M | ||
| Q3 24 | $-20.3M | $-67.0M | ||
| Q2 24 | $45.7M | $-77.0M |
自由现金流BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | $184.3M | $-100.8M | ||
| Q3 25 | $29.8M | $-92.7M | ||
| Q2 25 | $72.6M | $-110.7M | ||
| Q1 25 | $10.2M | $-167.8M | ||
| Q4 24 | $161.3M | $-79.5M | ||
| Q3 24 | $-25.0M | $-68.6M | ||
| Q2 24 | $40.7M | $-79.0M |
自由现金流率BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | 97.2% | -48.6% | ||
| Q3 25 | 16.3% | -58.0% | ||
| Q2 25 | 41.6% | -66.5% | ||
| Q1 25 | 6.0% | -120.5% | ||
| Q4 24 | 98.8% | -48.3% | ||
| Q3 24 | -15.3% | -49.2% | ||
| Q2 24 | 26.0% | -53.7% |
资本支出强度BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | 18.0% | 0.5% | ||
| Q3 25 | 4.7% | 0.8% | ||
| Q2 25 | 5.2% | 1.5% | ||
| Q1 25 | 4.8% | 1.0% | ||
| Q4 24 | 5.9% | 0.1% | ||
| Q3 24 | 2.8% | 1.2% | ||
| Q2 24 | 3.2% | 1.4% |
现金转化率BOHRARE
| Q1 26 | — | — | ||
| Q4 25 | 3.58× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | -0.50× | — | ||
| Q2 24 | 1.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BOH
| Net Interest Income | $151.0M | 79% |
| Noninterest Income | $41.3M | 21% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
